Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01930032 · ClinicalTrials.gov registry record
Pathogenic Mechanisms in C Diff Infection and Colitis
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT01930032 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT01930032 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about infection by Clostridium difficile (also known as C. difficile). C. difficile is a common bacterium (a germ that may cause disease) that can live in the human gut. Some people have it without having any symptoms. In other people it can cause illness ranging from mild diarrhea to severe colitis (infection of the colon). C. difficile makes toxins that damage the cells that line the colon. The study doctors want to find out how these toxins cause damage to the cells in the colon.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01930032
The ClinicalTrials.gov registry entry for NCT01930032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01930032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01930032 about?
NCT01930032 is a clinical study titled "Pathogenic Mechanisms in C Diff Infection and Colitis". The purpose of this study is to learn more about infection by Clostridium difficile (also known as C. difficile). C. difficile is a common bacterium (a germ that may cause disease) that can live in the human gut. Some people have it without having any symptoms. In other people it can cause illness r...
What is the current status of trial NCT01930032?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-08. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01930032?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.